These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13907352)

  • 1. Treatment of leukemia, lymphoma, and other malignant neoplasms with Vinblastine.
    HILL JM; LOEB E
    Cancer Chemother Rep; 1961 Dec; 15():41-61. PubMed ID: 13907352
    [No Abstract]   [Full Text] [Related]  

  • 2. Vincaleukoblastine in the treatment of malignant disease.
    WHITELAW DM; TEASDALE JM
    Can Med Assoc J; 1961 Sep; 85(10):584-91. PubMed ID: 13784890
    [No Abstract]   [Full Text] [Related]  

  • 3. Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.
    WARWICK OH; DARTE JM; BROWN TC; BEER CT; CUTTS JH; NOBLE RL
    Cancer Res; 1960 Aug; 20():1032-40. PubMed ID: 13842983
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral vinblastine.
    HODES ME; ROHN RJ; BOND WH; YARDLEY J
    Cancer Chemother Rep; 1961 Jun; 12():190-2. PubMed ID: 13714824
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with vinblastine sulfate.
    WARWICK OH; ALISON RE; DARTE JM
    Can Med Assoc J; 1961 Sep; 85(10):579-83. PubMed ID: 13783267
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies of vinblastine.
    FREI E; FRANZINO A; SHNIDER BI; COSTA G; COLSKY J; BRINDLEY CO; HOSLEY H; HOLLAND JF; GOLD GL; JONSSON U
    Cancer Chemother Rep; 1961 Jun; 12():125-9. PubMed ID: 13701670
    [No Abstract]   [Full Text] [Related]  

  • 7. Vincaleukoblastine (solid tumors).
    MOORE GE; WATNE AL
    Cancer Chemother Rep; 1961 Jun; 12():192-7. PubMed ID: 13772297
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of inoperable carcinoma of the lung by vinblastine sulphate: a preliminary report.
    MACFARLANE JC; DOUGHTY BJ; CROSBIE WA
    Br J Dis Chest; 1962 Apr; 56():64-9. PubMed ID: 14467829
    [No Abstract]   [Full Text] [Related]  

  • 9. Vincaleukoblastine. IV. A summary of two and one-half years' experience in the use of vinblastine.
    HODES ME; ROHNRJ ; BOND WH; YARDLEY JM; CORPENING WS
    Cancer Chemother Rep; 1962 Feb; 16():401-6. PubMed ID: 13907938
    [No Abstract]   [Full Text] [Related]  

  • 10. Vincaleukoblastine. III. Clinical trial with the oral preparation.
    HODES ME; ROHN RJ; BOND WH; YARDLEY J
    Cancer Chemother Rep; 1961 Oct; 14():129-38. PubMed ID: 13907937
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy in leukemia and malignant reticulosis].
    ARIENS EJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1919-22. PubMed ID: 13794222
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors.
    WALL RL; CONRAD FG
    Arch Intern Med; 1961 Sep; 108():456-82. PubMed ID: 13782776
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of the malignant lymphomas and leukemias.
    GAMBLE JF
    Med Ann Dist Columbia; 1962 Apr; 31():195-9. PubMed ID: 13896557
    [No Abstract]   [Full Text] [Related]  

  • 14. Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    N Engl J Med; 1961 Apr; 264():790-3. PubMed ID: 13752496
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects on the marrow of chemotherapy, used for the treatment of lymphomas and leukaemias.
    MADIGAN J; MOTTERAM R
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():194-5. PubMed ID: 14419682
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias.
    STUTZMAN L; RAZIS DV; SOKAL JE; AMBRUS JL; ROSS CA
    Cancer Chemother Rep; 1962 May; 18():31-5. PubMed ID: 13918060
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic spectrum of uracil-mustard, a new oral antitumor drug. With special reference to the effects of small dosage in lymphomas, chronic leukemias, and ovarian carcinoma.
    SHANBROM E; MILLER S; HAAR H; OPFELL R
    JAMA; 1960 Nov; 174():1702-5. PubMed ID: 13750663
    [No Abstract]   [Full Text] [Related]  

  • 18. Vincaleukoblastine. I. Preliminary clinical studies.
    HODES ME; ROHN RJ; BOND WH
    Cancer Res; 1960 Aug; 20():1041-9. PubMed ID: 14402218
    [No Abstract]   [Full Text] [Related]  

  • 19. VINCRISTINE IN THE TREATMENT OF NEOPLASTIC DISEASE.
    WHITELAW DM; KIM HS
    Can Med Assoc J; 1964 Jun; 90(25):1385-9. PubMed ID: 14158543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincaleukoblastine.
    NOBLE RL
    Can Med Assoc J; 1961 Sep; 85(10):610-1. PubMed ID: 13729372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.